Pure Global
NCT06207903

Navigating the Clinical Research Process for Mild Cognitive Impairment

Investigating Participation Behavior: An Observational Study in Mild Cognitive Impairment Clinical Trials
Power Life Sciences Inc.·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Study type
Observational
Sponsor & location
Primary sponsor
Power Life Sciences Inc.
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2025
End date
Feb 01, 2027
Enrollment
500 participants
Primary outcome

Rate of patients who decide to enroll in a mild cognitive impairment clinical research.,Number of mild cognitive impairment study participants who remain in clinical study until completion.

Summary

Participation in medical research usually favors a particular demographic group. But there is
 limited research available to explain what trial attributes affect the completion of these
 specific demographic groups.
 
 This trial will admit a wide range of data on the clinical trial experience of mild cognitive
 impairment patients to determine which factors prevail in limiting a patient's ability to
 join or finish a trial.
 
 It will also try to analyze data from the perspective of different demographic groups to
 check for recurring trends which might yield insights for the sake of future mild cognitive
 impairment patients.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06207903
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06207903 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.